– Assistant professor Nicole Loos-Bartlett presented on treatment resistant depression at a St. Luke’s Grand Rounds event.– Grand Rounds are educational events for healthcare providers to discuss medical problems and treatments.– Loos-Bartlett discussed lesser-known treatment options for treatment resistant depression, including inhaled ketamine, transcranial magnetic stimulation, and recent research on psilocybin and MDMA.– She emphasized the importance of discussing mental health solutions due to the shortage of mental health providers in Idaho.– Loos-Bartlett is a nurse practitioner with board certifications in psychiatric-mental health, adult gerontology acute care, and pediatrics. She also works at the Crisis Center of Southern Idaho.
Assistant professor Nicole Loos-Bartlett recently presented on treatment resistant depression at a St. Luke’s system-wide Grand Rounds event.
Grand Rounds are widely known in healthcare as structured educational events for providers to discuss medical problems and treatments. While they originated as doctors “made rounds” to patients, nowadays Grand Rounds resemble lecture events and are not held at the patients’ bedside.
Nicole Loos-Bartlett teaches nurse practitioner students in the School of Nursing.
Invited by St. Luke’s neurology department, Loos-Bartlett discussed lesser-known treatment options for treatment resistant depression. These include inhaled ketamine (Spravato), transcranial magnetic stimulation and recent research around psilocybin and methylenedioxymethamphetamine (MDMA) at academic institutions such as Harvard and Johns Hopkins.
Loos-Bartlett said it is crucial for providers to discuss developing mental health solutions since “every single county in Idaho has a critical shortage of mental health providers.”
Loos-Bartlett is a nurse practitioner with three board certifications in psychiatric-mental health, adult gerontology acute care and pediatrics. In addition to her own private practice, Loos-Bartlett is the medical director of the Crisis Center of Southern Idaho in Twin Falls where she frequently works with opioid detox patients.
Assistant professor recently presented on treatment resistant depression at a St. Luke’s system-wide Grand Rounds event. Grand Rounds are widely known in healthcare as structured educational events for providers to discuss medical problems and treatments. While they originated as doctors “made rounds” to patients, nowadays Grand Rounds resemble lecture events and are not held at the patients’ bedside.
In her presentation, Loos-Bartlett discussed lesser-known treatment options for treatment resistant depression. These include inhaled ketamine (Spravato), transcranial magnetic stimulation, and recent research around psilocybin and methylenedioxymethamphetamine (MDMA) at academic institutions such as Harvard and Johns Hopkins. These emerging treatment options offer hope for patients who have not responded well to traditional antidepressant medications.
One of the main reasons Loos-Bartlett stressed the importance of discussing developing mental health solutions is due to the critical shortage of mental health providers in Idaho. As covered by her, every single county in the state has a shortage, highlighting the need for innovative approaches to address mental health issues.
As a nurse practitioner, Loos-Bartlett brings a wealth of experience and expertise to the field of mental health. She holds three board certifications in psychiatric-mental health, adult gerontology acute care, and pediatrics. In addition to her work as an assistant professor, Loos-Bartlett also has her own private practice and serves as the medical director of the Crisis Center of Southern Idaho in Twin Falls. In her role at the Crisis Center, she frequently works with opioid detox patients, further demonstrating her dedication to providing comprehensive care for individuals struggling with mental health and substance abuse issues.
The presentation by Nicole Loos-Bartlett at the St. Luke’s Grand Rounds event highlights the importance of exploring new treatment options for individuals with treatment resistant depression. By discussing emerging therapies such as inhaled ketamine, transcranial magnetic stimulation, and research on substances like psilocybin and MDMA, healthcare providers can stay informed about the latest advancements in mental health treatment. This knowledge is crucial in addressing the critical shortage of mental health providers in Idaho and ensuring that patients receive the care they need.
When all is said and done, the presentation by Nicole Loos-Bartlett sheds light on the importance of ongoing education and collaboration among healthcare providers to improve mental health outcomes. By staying up to date with the latest research and exploring innovative treatment options, providers can better serve their patients and contribute to the advancement of mental healthcare as a whole.
